This podcast includes excerpts from an interview with Irv Weissman, of Stanford University, in which he recalls his early years studying immunology in mice and discusses more recent challenges he has faced when attempting to develop stem-cell-based therapies with industry. Narrated by Sarah E. Allan. To listen to this podcast, visit

This content is only available via PDF.

Supplementary information